Baseline Knowledge of Stress Urinary Incontinence Among Urogynecology Patients (SUI)

April 20, 2026 updated by: Dr. Patricia Lee, Sunnybrook Health Sciences Centre

Knowledge, Awareness, and Understanding of Stress Urinary Incontinence in Patients Attending a Urogynecology Clinic

The goal of this prospective study is to assess whether a standardized educational flyer (pamphlet) improves knowledge about stress urinary incontinence (SUI) in adult females attending a urogynecology clinic. It will also explore how participant characteristics relate to treatment preferences.

The main questions it aims to answer are:

Does reading a standardized SUI patient information flyer improve participants' knowledge of SUI? How do patient characteristics influence treatment preferences for SUI?

Participants will:

Complete a self-administered questionnaire assessing knowledge of SUI, including its definition, pathophysiology, risk factors, natural history, and treatment options (this questionnaire is not part of standard care).

Review a standardized SUI educational flyer during their clinic visit. Complete the same questionnaire again after reading the pamphlet to assess any change in knowledge.

Questionnaire scores before and after reading the flyer will be compared. Secondary outcomes include participant characteristics and reported treatment preferences.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

This prospective study will recruit female adult patients with a clinical diagnosis of stress urinary incontinence (SUI) presenting to a urogynecology clinic at Sunnybrook Health Centre. Consenting participants will complete a self-administered questionnaire (15-item questionnaire) assessing knowledge related to SUI definition, pathophysiology, risk factors, natural history, and available treatment options. Demographic and clinical data, including age, education level, parity, menopausal status, symptom severity, and prior exposure to SUI treatment, SUI treatment preferences and level of education, will be collected.

A standardized patient information SUI flyer by the American Urogynecology Society (AUGS) will be given to the participant to read. Right after reading the flyer, participants will be re-tested with the same self-administered questionnaire (before leaving the clinic visit).

The primary outcome will be the change in the questionnaire (SUI knowledge) total score.

Secondary outcomes include patient characteristics and their treatment preferences.

Descriptive statistics will be used.

Participants who consent to being contacted for study-related updates will be asked to provide their preferred contact information.

Participant contact information will be stored separately from study data in a secure, password-protected electronic file accessible only to authorized members of the research team. Each participant will be assigned a unique study ID, and identifying information will not be linked to questionnaire responses or study outcomes.

Study Type

Observational

Enrollment (Estimated)

90

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

  • Canada
    • Onatrio
      • Toronto, Onatrio, Canada, M4N 3M5
        • Sunnybrook Health Sciences Centre
        • Contact:
        • Sub-Investigator:
          • Aysha Nedham, MD, BSc, FRCSC

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Population will be new patients referred to Urogynecology clinic at Sunnybrook Health Sciences Centre with clinical presentation of SUI

Description

Inclusion Criteria:

  • Participants are patients referred to Sunnybrook Health Sciences Centre Urogynecology Clinics with the condition of SUI.
  • ≥ 18 years old
  • Female
  • Able to provide informed consent and communicate in English

Exclusion Criteria:

  • Under the age of 18 years
  • Urge-predominant mixed urinary incontinence or pure urinary urge incontinence
  • Inability to respond to research questionnaires in English
  • Unable to provide informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
All participants receive the same intervention and complete the same questionnaire
Consenting new patients presenting to a urogynecology clinic with SUI will 1) complete a 15-item questionnaire upon arrival in the clinic (pre intervention) , 2) will read the SUI educational flyer and 3) complete a post-knowledge questionnaire right after reading the flyer.
Other: 15 Item Questionnaire
Participants will complete a 15-item questionnaire assessing baseline knowledge of SUI. They will then review a standardized patient education Flyer developed by the American Urogynecologic Society (AUGS) about SUI and complete the same questionnaire again right after reading the flyer.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in the total score of the SUI knowledge questionnaire
Time Frame: At the same clinic visit: from enrollment to completing the post-intervention SUI Knowledge questionnaire
The change in SUI knowledge questionnaire total score (15-item questionnaire, with each correct answer equals 1 point, maximum number of points is 15) before and right after reading the AUGS SUI flyer.
At the same clinic visit: from enrollment to completing the post-intervention SUI Knowledge questionnaire

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sunnybrook Health Sciences Centre

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

  • 11. Dmochowski RR, Newman DK, Johnson CP, Oefelein MG. Patient education in urinary incontinence. Urol Clin North Am. 2010;37(4):495-506. 12. Shaw C, Tansey R, Jackson C, Hyde C, Allan R. Barriers to help seeking in people with urinary symptoms. Fam Pract. 2001;18(1):48-52.
  • 10. Kinchen KS, Burgio K, Diokno AC, Fultz NH, Bump R, Obenchain R. Factors associated with women's decisions to seek treatment for urinary incontinence. J Womens Health. 2003;12(7):687-698.
  • 9. Shaw C, Gupta RD, Bushnell DM, Martin ML. The extent and severity of urinary incontinence amongst women in the UK. BJOG. 2006;113(4):414-421.
  • 8. Coyne KS, Wein A, Nicholson S, Kvasz M, Chen CI, Milsom I. Comorbidities and personal burden of urgency urinary incontinence. BJU Int. 2014;113(3):438-444.
  • 7. Subak LL, Brown JS, Kraus SR, Brubaker L, Lin F, Richter HE, et al. The costs of urinary incontinence for women. Obstet Gynecol. 2006;107(4):908-916.
  • 6. Hannestad YS, Rortveit G, Sandvik H, Hunskaar S. A community-based epidemiological survey of female urinary incontinence. J Clin Epidemiol. 2000;53(11):1150-1157.
  • 5. Milsom I, Altman D, Lapitan MC, Nelson R, Sillén U, Thom D. Epidemiology of urinary incontinence and other lower urinary tract symptoms. In: Abrams P, Cardozo L, Khoury S, Wein A, editors. Incontinence. 4th ed. Paris: Health Publication Ltd; 2009.
  • 4. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology of lower urinary tract function. Neurourol Urodyn. 2003;21(2):167-178.
  • 3. Minassian VA, Drutz HP, Al-Badr A. Urinary incontinence as a worldwide problem. Int J Gynaecol Obstet. 2003;82(3):327-338.
  • 2. Wu JM, Vaughan CP, Goode PS, Redden DT, Burgio KL, Richter HE, Markland AD. Prevalence and trends of symptomatic pelvic floor disorders in US women. Obstet Gynecol. 2014;123(1):141-148.
  • 1. Nygaard I, Barber MD, Burgio KL, Kenton K, Meikle S, Schaffer J, et al. Prevalence of symptomatic pelvic floor disorders in US women. JAMA. 2008;300(11):1311-1316.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

April 30, 2026

Primary Completion (Estimated)

July 31, 2026

Study Completion (Estimated)

July 31, 2026

Study Registration Dates

First Submitted

April 8, 2026

First Submitted That Met QC Criteria

April 20, 2026

First Posted (Actual)

April 28, 2026

Study Record Updates

Last Update Posted (Actual)

April 28, 2026

Last Update Submitted That Met QC Criteria

April 20, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 7119

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stress Urinary Incontinence (SUI)

Clinical Trials on 15 Item Questionnaire

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Spain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe